Primary Navigation for the CDC Web Site
CDC en Español
Cancer Prevention and Control
divider
E-Mail Icon E-mail this page
Printer Friendly Icon Printer-friendly version
E-Mail Updates Icon Get e-mail updates
divider
 View by Topic
bullet About Us
bullet Resource Library
bullet Publications Available Online
bullet Print Publication Ordering System
bullet Scientific Articles
bullet Comprehensive Cancer Control Plans Search
bullet Preventive Cancer Screening
bullet Program Contacts
bullet Partners
bullet Data
bullet Newsroom
bullet Site Map

Contact Information Centers for Disease
Control and Prevention
Division of Cancer
Prevention and Control
4770 Buford Hwy, NE
MS K-64
Atlanta, GA 30341-3717

Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760

E-mail: cdcinfo@cdc.gov

Submit a Question Online

Scientific Articles about Breast Cancer

Return to index

This page contains a list of citations for selected publications authored by CDC's Division of Cancer Prevention and Control (DCPC) staff members. Fiscal years begin October 1 and end September 30; for example, fiscal year 2006 began October 1, 2005 and ended September 30, 2006.

Fiscal Year 2009

Kapp JM, Ryerson AB, Coughlin SS, Thompson TD. Racial and ethnic differences in mammography use among U.S. women younger than age 40. Breast Cancer Research and Treatment 2009;113(2):327–337.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW. Race and triple negative threats to breast cancer survival: A population-based study in Atlanta, GA. Breast Cancer Research and Treatment 2009;113(2):357–370.

Ryerson AB, Miller JW, Eheman CR, Leadbetter S, White MC. Recent trends in U.S. mammography use from 2000–2006: A population-based analysis. Preventive Medicine 2008;47(5):477–482.

Fiscal Year 2008

Baron RC, Rimer BK, Breslow RA, Coates RJ, Kerner J, Melillo S, Habarta N, Kalra GP, Chattopadhyay S, Wilson KM, Lee NC, Mullen PD, Coughlin SS, Briss PA; Task Force on Community Preventive Services. Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening: a systematic review. American Journal of Preventive Medicine 2008;35(1 Suppl):S34–55.

Baron RC, Rimer BK, Coates RJ, Kerner J, Kalra GP, Melillo S, Habarta N, Wilson KM, Chattopadhyay S, Leeks K, Task Force on Community Preventive Services. Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening: A systematic review. American Journal of Preventive Medicine 2008;35(1 Suppl):S56–66.

Baron RC, Rimer BK, Coates RJ, Kerner J, Mullen PD, Chattopadhyay S, Briss PA; Task Force on Community Preventive Services. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers. American Journal of Preventive Medicine 2008;35(1 Suppl):S26–33.

Breslow RA, Rimer BK, Baron RC, Coates RJ, Kerner J, Wilson KM, Lee NC, Mullen PD, Coughlin SS, Briss PA. Introducing the Community Guide's reviews of evidence on interventions to increase screening for breast, cervical, and colorectal cancers. American Journal of Preventive Medicine 2008;35(1 Suppl):S14–20.

Coughlin SS, Leadbetter S, Richards T, Sabatino SA. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Social Science and Medicine 2008;66(2):260–275.

Coughlin SS, Sabatino SA, Shaw KM. What factors are associated with where women undergo clinical breast examination? Results from the 2005 National Health Interview Survey.* The Open Clinical Cancer Journal 2008;2(1):32–43.

Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Cancer 2008;112(3):626–635.

Ekwueme DU, Hall IJ, Richardson LC, Gardner JG, Royalty J, Thompson TD. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program. Cancer 2008;113(3):592–601.

Gregory-Mercado KY, Will J, True S, Royalty J, Starcher ET 2nd, Khavjou O, Helsel W, Kammerer W, Howe W. A combined approach to women's health is associated with a greater likelihood of repeat mammography in a population of financially disadvantaged women. Preventing Chronic Disease 2007;4(4):A89.

Hahn KM, Bondy ML, Selvan M, Lund MJ, Liff JM, Flagg EW, Brinton LA, Porter P, Eley JW, Coates RJ. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. American Journal of Epidemiology 2007;166(9):1035–1044.

Hall IJ, Middlebrooks A, Coughlin SS. Population prevalence of first-degree family history of breast and ovarian cancer in the United States: implications for genetic testing. The Open Health Services and Policy Journal 2008;1(1):34–37.

Kagawa-Singer M, Pourat N, Breen N, Coughlin S, McLean TA, McNeel TS, Ponce NA. Breast and cervical cancer screening rates of subgroups of Asian American women in California. Medical Care Research and Review 2007;64(6):706–730.

Norman SA, Russell Localio A, Weber AL, Coates RJ, Zhou L, Bernstein L, Malone KE, Marchbanks PA, Weiss LK, Lee NC, Nadel MR. Protection of mammography screening against death from breast cancer in women aged 40–64 years. Cancer Causes and Control 2007;18(9):909–918.

Richardson LC, Wang W, Hartzema AG, Wagner S. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Breast Journal 2007;13(6):581–587.

Sabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM. Disparities in mammography use among US women aged 40–64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Medical Care 2008;46(7):692–700.

Sabatino SA, Habarta N, Baron RC, Coates RJ, Rimer BK, Kerner J, Coughlin SS, Kalra GP, Chattopadhyay S; Task Force on Community Preventive Services. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers: Systematic reviews of provider assessment and feedback and provider incentives. American Journal of Preventive Medicine 2008;35(1 Suppl):S67–74.

Sabatino SA, McCarthy EP, Phillips RS, Burns RB. Breast cancer risk assessment and management in primary care: Provider attitudes, practices, and barriers. Cancer Detection and Prevention 2007;31(5):375–383.

Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, Jackson-Thompson J, Arambula Solomon TG. Breast cancer incidence among American Indian and Alaska Native women: US, 1999–2004. Cancer 2008;113(S5):1191–1202.

Wu X, Richardson LC, Khan A, Fulton JP, Cress RD, Shen T, Wolf HJ, Bolick-Aldrich S, Chen VW. Survival differences between non-Hispanic black and non-Hispanic white women with localized breast cancer: The impact of guideline-concordant therapy. Journal of the National Medical Association 2008;100(5):490–498.

Fiscal Year 2007

Abrahamson PE, Gammon MD, Lund MJ, Britton JA, Marshall SW, Flagg EW, Porter PL, Brinton LA, Eley JW, Coates RJ. Recreational physical activity and survival among young women with breast cancer. Cancer 2006;107(8):1777–1785.

Abrahamson PE, Gammon MD, Lund MJ, Flagg EW, Porter PL, Stevens J, Swanson CA, Brinton LA, Eley JW, Coates RJ. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2006;15(10):1871–1877.

Breen N, Cronin KA, Meissner HI, Taplin SH, Tangka FK, Tiro JA, McNeel TS. Reported drop in mammography: is this cause for concern? Cancer 2007;109(12):2405–2409.

Coughlin SS, Berkowitz Z, Hawkins NA, Tangka F. Breast and colorectal cancer screening and sources of cancer information among older women in the United States: results from the 2003 Health Information National Trends Survey. Preventing Chronic Disease 2007;4(3):A57.

Richardson LC, Hall IJ. Diagnostic accuracy of the Gail Model in the Black Women's Health Study. Breast Journal 2007;13(4):329–331.

Ryerson AB, Miller J, Eheman CR, White MC. Use of mammograms among women aged ≥ 40 years—United States, 2000–2005. MMWR 2007;56(3):49–51.

Stewart SL, Sabatino SA, Foster SL, Richardson LC. Decline in breast cancer incidence—United States, 1999–2003. MMWR 2007;56(22):549–553.

Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Research and Treatment 2007;103(1):93–102.

Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years. Cancer Epidemiology, Biomarkers and Prevention 2007;16(9):1822–1827.

Fiscal Year 2006

Bobo JK, Shapiro JA, Brustrom J. Efforts to locate low-income women for a study on mammography rescreening: implications for public health practice. Journal of Community Health 2006;31(3):249–261.

Coughlin SS, King J, Richards TB, Ekwueme DU. Breast cancer screening and socioeconomic status—35 metropolitan areas, 2000 and 2002. MMWR 2005;54(39):981–985.

Eheman CR, Benard VB, Blackman D, Lawson HW, Anderson C, Helsel W, Lee NC. Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States). Cancer Causes and Control 2006;17(1):29–38.

Kodl MM, Lee JW, Matthews AK, Cummings SA, Olopade OI. Correlates of depressive symptoms among women seeking cancer genetic counseling and risk assessment at a high-risk cancer clinic. Journal of Genetic Counseling 2006;15(4):267–276.

Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, Marchbanks PA, Simon MS, McDonald JA, Norman SA, Strom BL, Burkman RT, Ursin G, Deapen D, Weiss LK, Folger S, Madeoy JJ, Friedrichsen DM, Suter NM, Humphrey MC, Spirtas R, Ostrander EA. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Research 2006;66(16):8297–8308.

Norman SA, Localio AR, Zhou L, Weber AL, Coates RJ, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Lee NC, Nadel MR. Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States). Cancer Causes and Control 2006;17(7):921–929.

Peipins LA, Shapiro JA, Bobo JK, Berkowitz Z. Impact of women's experiences during mammography on adherence to rescreening (United States). Cancer Causes and Control 2006;17(4):439–447.

Richardson LC, Tian L, Voti L, Hartzema AG, Reis I, Fleming LE, Mackinnon J. The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida. American Journal of Public Health 2006;96(1):160–166.

Sabatino SA, Burns RB, Davis RB, Phillips RS, McCarthy EP. Breast cancer risk and provider recommendation for mammography among recently unscreened women in the United States. Journal of General Internal Medicine 2006;21(4):285–291.

Tangka FK, Dalaker J, Chattopadhyay SK, Gardner JG, Royalty J, Hall IJ, Degroff A, Blackman DK, Coates RJ. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002–2003 (United States). Cancer Causes and Control 2006;17(9):1145–1154.

Voti L, Richardson LC, Reis IM, Fleming LE, Mackinnon J, Coebergh JW. Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities. Cancer 2006;106(1):201–207.

Voti L, Richardson LC, Reis I, Fleming LE, Mackinnon J, Coebergh JW. The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Research and Treatment 2006;95(1):89–95.

Fiscal Year 2005

Hall IJ, Moorman PG, Millikan RC, Newman B. Comparative analysis of breast cancer risk factors among African-American women and white women. American Journal of Epidemiology 2005;161(1):40–51.

Joslyn SA, Foote ML, Nasseri K, Coughlin SS, Howe HL. Racial and ethnic disparities in breast cancer rates by age: North American Association of Central Cancer Registries Breast Cancer Project. Breast Cancer Research and Treatment 2005;92(2):97–105.

Saslow D, Hannan J, Osuch J, Alciati MH, Baines C, Barton M, Bobo JK, Coleman C, Dolan M, Gaumer G, Kopans D, Kutner S, Lane DS, Lawson H, Meissner H, Moorman C, Pennypacker H, Pierce P, Sciandra E, Smith R, Coates R. Clinical breast examination: Practical recommendations for optimizing performance and reporting.* CA: A Cancer Journal for Clinicians 2004;54(6):327–344.

Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiology, Biomarkers and Prevention 2005;14(8):2009–2014.

Fiscal Year 2004

Bobo JK, Shapiro JA, Schulman J, Wolters CL. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program.* Cancer Epidemiology, Biomarkers and Prevention 2004;13(4):620–630.

Coughlin SS, Uhler RJ, Bobo JK, Caplan L. Breast cancer screening practices among women in the United States, 2000. Cancer Causes and Control 2004;15(2):159–170.

Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: What are the linkages to chronic disease risk? Preventing Chronic Disease 2004;1(1):1–20.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50–64 years.* Cancer Epidemiology, Biomarkers and Prevention 2003(11);12:1175–1181.

French C, True S, McIntyre R, Sciulli M, Maloy K. State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: A collaborative effort among government agencies. Public Health Reports 2004;119(3):279–285.

Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 2004;100(8):1595–1604.

Hall HI, Jamison PM, Coughlin SS. Breast and cervical cancer mortality in the Mississippi Delta, 1979–1998. Southern Medical Journal 2004;97(3):264–272.

Hall HI, Jamison PM, Coughlin SS, Uhler RJ. Breast and cervical cancer screening among Mississippi Delta women. Journal of Health Care for the Poor and Underserved 2004;15(3):375–389.

Hutton BJ, Bradt EK, Chen JH, Gobrecht P, O'Connell J, Pedulla A, Signorelli T, Bisner S, Hoffman DP, Lawson HW. Breast cancer-screening data for assessing quality of services—New York State, 2000–2003. MMWR 2004;53(21):455–457.

Jacobellis J, Martin L, VanEenwyk J, Bradley LA, Kassim S, Jorgensen C, Litch JA, Myers MF. Genetic testing for breast and ovarian cancer susceptibility: Evaluating direct-to-consumer marketing—Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR 2004;53(27):603–606.

Norman SA, Berlin JA, Weber AL, Strom BL, Daling JR, Weiss LK, Marchbanks PA, Bernstein L, Voigt LF, McDonald JA, Ursin G, Liff JM, Burkman RT, Malone KE, Simon MS, Folger SG, Deapen D, Wingo PA, Spirtas R. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women. Cancer Causes and Control 2003;14(10):933–943.

Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma: Study of young African-American and white women in Atlanta, Georgia. Cancer 2004;100(12):2533–2542.

Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-Barbash R, Bobo JK, Lee NC, Wallis MG, Patnick J, Kerlikowske K. Comparison of screening mammography in the United States and the United Kingdom.* Journal of the American Medical Association 2003;290(16):2129–2137.

Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Reproductive history and mortality after breast cancer diagnosis.* Obstetrics and Gynecology 2004;104(1):146–154.

Wingo PA, Cardinez C, Landis SH, Greenlee R, Anderson RN, Ries LAG, Thun MJ. Long-term trends in cancer mortality in the United States, 1930–1998. Cancer 2003;97(12 Suppl):3133–3275.

Wingo PA, Jamison PM, Young JL, Gargiullo P. Population-based statistics for women diagnosed with inflammatory breast cancer (United States). Cancer Causes and Control 2004;15(3):321–328.

Young Jr JL, Ward KC, Wingo PA, Howe HL. The incidence of malignant non-carcinomas of the female breast. Cancer Causes and Control 2004;15(3):313–319.

Fiscal Year 2003

Althuis MD, Brogan DR, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA. Hormonal content and potency of oral contraceptives and breast cancer risk among young women. British Journal of Cancer 2003;88(1):50–57.

Collaborative Group on Hormonal Factors in Breast Cancer (including Wingo PA and Coates RJ). Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002;360(9328):187–195.

Coughlin SS, Lee NC. Annual screening may not decrease breast cancer deaths among women aged 40 to 49 years. Cancer Treatment Reviews 2003;29(1):55–57.

Coughlin SS, Thompson TD, Seeff L, Richards T, Stallings F. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern United States. Cancer 2002;95(10):2211–2227.

Coughlin SS, Uhler RJ, Richards T, Wilson K. Breast and cervical cancer screening practices among Hispanic and non-Hispanic women residing near the United States-Mexico border, 1999–2000. Family and Community Medicine 2003;26(2):130–139.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 2002;95(12):2455–2464.

Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L, Malone KE, Ursin G, Strom BL, Norman SA, Wingo PA, Burkman RT, Berlin JA, Simon MS, Spirtas R, Weiss LK. Oral contraceptives and breast cancer risk in white and black women. New England Journal of Medicine 2002;346(26):2025–2032.

McTiernan A, Kooperberg C, White C, Wilcox S, Coates RJ, Adams-Campbell LL, Woods N, Ockene J. Recreational physical activity and the risk of breast cancer in postmenopausal women: The Women's Health Initiative Cohort Study. Journal of the American Medical Association 2003;290(10):1331–1336.

Norman SF, Russell L, Zhou L, Bernstein L, Coates RJ, Flagg EW, Marchbanks PA, Malone KE, Weiss LK, Lee NC, Nadel MR. Validation of self-reported screening mammography histories among women with and without breast cancer. American Journal of Epidemiology 2003;158(3):264–271.

Porter PL, Lund MJ, Eley JW, Coates RJ, Flagg EW, Liff JM, Lin M-G, Yuan X, Schmidt J, Stafford S. Abnormal expression of G1 cell cycle proteins in breast tumors of African Americans. Breast Cancer Research and Treatment 2002;76:S84.

Potischman N, Coates RJ, Swanson CA, Carroll RJ, Daling JR, Brogan DR, Gammon MD, Midthune D, Curtin J, Brinton LA. Increased risk of early stage breast cancer related to consumption of sweet foods among women less than age 45. Cancer Causes and Control 2002;13(10):937–946.

Weiss LK, Burkman RT, Cushing-Haugen KL, Voigt LF, Simon MS, Daling JR, Norman SA, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Berlin JA, Weber AL, Doody DR, Wingo PA, McDonald JA, Malone KE, Folger SG. Hormone replacement therapy regimens and breast cancer risk.* Obstetrics and Gynecology 2002;100(6):1148–1158.

Fiscal Year 2002

Barr JK, Franks AL, Lee NC, Herther P, Schachter M. Factors associated with continued participation in mammography screening. Preventive Medicine 2001;33(6):661–667.

Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, Potischman N, Malone KE, Brogan DJ, Daling JR, Brinton LA. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. American Journal of Epidemiology 2002;156(6):507–516.

Coughlin SS, Thompson TD, Hall HI, Logan P, Uhler RJ. Breast and cervical cancer carcinoma screening among women in rural and non-rural areas of the United States, 1998–1999. Cancer 2002;94(11):2801–2812.

Coughlin SS, Uhler RJ. Breast and cervical cancer screening among Hispanic women in the United States and Puerto Rico, 1998–1999. Preventive Medicine 2002;34(2):242–251.

Coughlin SS, Wilson KM. Breast and cervical cancer screening among migrant and seasonal farm workers: A review. Cancer Detection and Prevention 2002;26(3):203–209.

Gargiullo P, Wingo PA, Coates RJ, Thompson TD. Recent trends in mortality rates for four major cancers, by sex and race/ethnicity—United States, 1990–1998. MMWR 2002;51(3):49–53.

Hall HI, Uhler RJ, Coughlin SS, Miller DS. Breast and cervical cancer screening among Appalachian women.* Cancer Epidemiology, Biomarkers and Prevention 2002;11(1):137–142.

Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B. Race, anthropometric factors, and stage at diagnosis of breast cancer. American Journal of Epidemiology 2001;153(3):284–291.

Resha K. NBCCEDP: Improves access to lifesaving cancer screening services. Hematology Oncology News and Issues 2002;1:27–29.

Saraiya M, Lee NC, Blackman D, Smith MJ, McKenna M. Observations from the CDC: An assessment of Pap smears and hysterectomies among women in the United States. Journal of Women's Health and Gender-Based Medicine 2002;11(2):103–109.

Fiscal Year 2001

Barr JK, Franks AL, Lee NC, Antonucci DM, Rifkind S, Schachter M. A randomized intervention to improve ongoing participation in mammography. American Journal of Managed Care 2001;7(9):887–894.

Benard VB, Lee NC, Piper M, Richardson L. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991–1998 (United States). Cancer Causes and Control 2001;12(1):61–68.

Bobo JK. Controversial role of clinical breast examinations in cancer screening programs. Symposium session organized and chaired for the Congress of Epidemiology 2001 Meeting in Toronto, Canada, June 2001. American Journal of Epidemiology 2001;153:S7.

Bobo JK, Lee NC. Factors associated with accurate cancer detection during a clinical breast examination. Annals of Epidemiology 2000;10(7):463.

Breslow R, Ballard-Barbash R, Wideroff L, Graubard B. Long-term recreational physical activity and breast cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up study.* Cancer Epidemiology, Biomarkers and Prevention 2001;10(7):805–808.

Caplan LS, May DS, Richardson LC. Time to diagnosis and treatment of breast cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991–1995. American Journal of Public Health 2000;90(1):130–134.

Coates RJ, Uhler RJ, Brogan, DJ, Gammon MD, Malone KE, Swanson CA, Flagg EW, Brinton LA. Patterns and predictors of the breast cancer detection methods in women under 45 years of age (United States). Cancer Causes and Control 2001;12(5):431–442.

Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B. Race, anthropometric factors, and stage at diagnosis of breast cancer.* American Journal of Epidemiology 2001;153(3):284–291.

Richardson LC, Schulman J, Sever LS, Coates RJ, Lee NC. Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992–1995. Breast Cancer Research and Treatment 2001;69(2):133–142.

Fiscal Year 2000

Blackman DK, Bennett EM, Miller DS. Trends in self-reported use of mammograms (1988–1997) and papanicolaou tests (1991–1997) Behavioral Risk Factor Surveillance System. MMWR 1999;48(SS–06):1–22.

Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program, 1995–1998. Journal of the National Cancer Institute 2000;92(12):971–976.

Brinton LA, Gammon MD, Coates RJ, Hoover RN. Tubal ligation and risk of breast cancer. British Journal of Cancer 2000;82(9):1600–1604.

Coughlin SS, Uhler RJ. Breast and cervical cancer screening practices among Asian and Pacific Islander women in the United States, 1994–1997.* Cancer Epidemiology, Biomarkers and Prevention 2000;9(6):597–603.

Coughlin SS, Uhler RJ, Blackman DK. Breast and cervical cancer screening practices among American Indian and Alaska Native women in the United States, 1992–1997. [published erratum appears in Preventive Medicine 2000;30(4):348]. Preventive Medicine 1999;29:287–295.

Hall HI, Rogers JD, Weir HK, Miller DS, Uhler RH. Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S., 1976–1996. Cancer 2000;89(7):1593–1602.

Hall HI, Newman B, Millikan RC, Moorman PG. Body size and breast cancer risk among black and white women: the Carolina Breast Cancer Study. American Journal of Epidemiology 2000;151(8):754–764.

Lawson HW, Henson RM, Bobo JK, Kaeser MK. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR 2000;49(RR–02):35–55.

May DS, Lee NC, Richardson LC, Giustozzi AG, Bobo JK. Mammography and breast cancer detection by race and Hispanic ethnicity: Results from a national program. Cancer Causes and Control 2000;11(8):697–705.

*Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.

Page last reviewed: January 12, 2009
Page last updated: January 12, 2009
Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention
1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
USA.govDHHS Department of Health
and Human Services